New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:40 EDTMDXGMiMedx EpiFix allograft awarded coverage by HCSC
MiMedx Group announced that Health Care Services Corporation, HCSC, has confirmed that the company's EpiFix allograft has been awarded reimbursement coverage. HCSC has approved the reimbursement of EpiFix for the indications as prescribed by the physician, including wound care, soft tissue replacement or repairs in burns, cardiovascular applications, treatment of ocular surfaces, and the application as a surgical barrier in knee or spine surgeries. The company also reported that its EpiFix allograft currently has reimbursement approval from 12 state Medicaid Programs.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:16 EDTMDXGPiper Jaffray and the Alliance for Regenerative Medicine co-host conference
3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link
March 23, 2015
17:48 EDTMDXGGovernment declines to intervene in action against MiMedx
Subscribe for More Information
12:04 EDTMDXGMiMedx repeats view of FY15 revenue $175M-$190M, consensus $186.24M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use